QSS
AGIO icon

Quantitative Systematic Strategies’s Agios Pharmaceuticals AGIO Stock Holding History

Quantitative Systematic Strategies’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,661
Closed -$241K – 453
2021
Q1 		$241K Sell
4,661
-8,716
-65% -$432K 0.04% 519
2020
Q4 		$580K Sell
13,377
-10,480
-44% -$414K 0.08% 360
2020
Q3 		$835K Buy
23,857
+3,736
+19% +$164K 0.15% 207
2020
Q2 		$1.08M Buy
20,121
+6,774
+51% +$314K 0.21% 154
2020
Q1 		$474K Sell
13,347
-5,662
-30% -$262K 0.39% 90
2019
Q4 		$908K Buy
+19,009
New +$718K 0.13% 241

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantitative Systematic Strategies's AGIO Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of Agios Pharmaceuticals (AGIO) in Q2 2021, closing a stake of 4,661 shares — an estimated $241K sold.

Quantitative Systematic Strategies first reported a position in AGIO in Q4 2019 and held it in 6 quarters. The position peaked at $1.08M in Q2 2020. 185 funds tracked by Wall St. Rank hold AGIO as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining Agios Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,661 Agios Pharmaceuticals shares in Q2 2021, an estimated $241K.
  • Quantitative Systematic Strategies first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • Quantitative Systematic Strategies's Agios Pharmaceuticals position peaked at $1.08M in Q2 2020.
  • 185 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.